Search

You searched for "Prostate"

502 results found

Prostate Cancer UK: PSA Consensus Conference 2024

20 September 2024
During the conference, you'll get up-to-date information on the latest consensus regarding the PSA blood test. You'll also be able to discuss the diagnostic process for secondary care and learn how to proactively manage conversations about prostate health with patients who are at higher risk. You’ll have plenty of opportunities to ask questions, interact with peers, and apply what you learn through engaging case studies. 9am – 12.30pm

BXTAccelyon becomes global distribution partner for new online prostate MRI self-learning tool to enhance prostate cancer diagnosis

6 May 2020 | Contracts & Distributors
BXTAccelyon, the leading low dose rate (LDR) brachytherapy partner to hospitals and clinics worldwide, and distribution partner for PrecisionPoint™, the...

Prostate Scotland Robotic Training, Fellowship, Clinical Visit & Research Awards

17 September 2024 | Research & Development, Awards, Conferences & Anniversaries, Charities
Prostate Scotland, in association with The Urology Foundation, has a number of awards available to support the training of urologists, surgery nurses and first surgical assistants in Scotland in robotic assisted prostate cancer surgery. The awards – ranging in value...

Fusion Bx 2.0 targeted prostate biopsy solution receives CE Mark

4 November 2019 | Research & Development
Focal Healthcare, an innovator of image-guided prostate cancer technology, has received CE Mark for its Fusion BxTM 2.0 prostate fusion biopsy solution.

EAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer

5 December 2024 -6 December 2024
Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

27 February 2025 -28 February 2025
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth.

Announcing a new specialist distributor of medical devices for prostate cancer

10 January 2022 | Contracts & Distributors, Research & Development
Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

FUJIFILM Healthcare Europe launches a dedicated prostate fusion imaging platform

8 July 2022 | Research & Development
FUJIFILM Healthcare Europe is pleased to have unveiled the ARIETTA™ 65 IntuitiveFusion.

Prostate Cancer UK warns of over 8,600 ‘missing men’ as referrals drop by 52,000

5 May 2021 | Research & Development, COVID-19
The Covid-19 pandemic has led to around 52,000 (28%) fewer urgent prostate cancer referrals in England alone, according to statistics shared by Prostate Cancer UK. It’s estimated that more than 8,600 fewer men started treatment for...

Prostate Cancer

The Prostate Days: diagnostic & intervention

17 June 2020 -18 June 2020

MRI Masterclass in Prostate Cancer for Urologists

6 September 2019